Snezana is a myeloma patient the president of the Serbian Association of Myeloma Patients (Udruženje obolelih od multiplog mijeloma Srbije). She spent years working as a business consultant covering finance, regulatory frameworks, international trade and distribution and also served as finance director with extensive experience at board level. Snezana’s mission is sharing knowledge, experiences, advocacy strategies, and developing collaboration between different EU regions to improve the capacities of CEE country myeloma associations.
A second bispecific antibody is approved as a fourth-line treatment for myeloma in England and Wales
After the approval of the first bispecific antibody for myeloma last month, the National Institute for Health and Care Excellence (NICE, the United Kingdom’s public body for medicine appraisals) approved…